Madrigal Pharmaceuticals appoints John C. Reed to board of directors

MDGL•2026-11-03

Madrigal Pharmaceuticals appointed John C. Reed to its board in August 2026.

1. Board appointment

Reed serves as Johnson & Johnson’s executive vice president for Innovative Medicine R&D. He previously held executive leadership roles at Sanofi and Roche.

Madrigal Pharmaceuticals appoints John C. Reed to board of directors

1. Board appointment

Related News

XPLR Infrastructure reports Q3 2026 net income of $51 million

Madrigal rises after swinging to Q3 profit

CVR Energy launches $750 million common stock offering

ZoomInfo partners with Notion to bring sales intelligence into Notion AI

KeyCorp's KeyBanc Capital Markets agrees to acquire Atlantic-Pacific Capital